Cancer Research and Treatment

The clinicopathologic of pulmonary adenocarcinoma transformation to small cell lung cancer

Haiyan Yang, Li Liu, Chunhua Zhou, Yi Xiong, Yijuan Hu, Nong Yang, Jingjing Qu

Histological transformation of adenocarcinoma to small cell carcinoma lung as a rare mechanism of resistance to epidermal growth factor receptor-tyrosine kinase inhibitors: Report of a case with review of literature

Monalisa Hui, ShantveerG Uppin, BalaJoseph Stalin, G Sadashivudu

Predictive Factors for Switched EGFR-TKI Retreatment in Patients with EGFR-Mutant Non-Small Cell Lung Cancer

Byoung Soo Kwon, Ji Hyun Park, Woo Sung Kim, Joon Seon Song, Chang-Min Choi, Jin Kyung Rho, Jae Cheol Lee

Tuberculosis and Respiratory Diseases.2017; 80(2): 187. CrossRef

Acquired Resistance to Erlotinib in EGFR Mutation-Positive Lung Adenocarcinoma among Hispanics (CLICaP)

Andrés F. Cardona, Oscar Arrieta, Martín Ignacio Zapata, Leonardo Rojas, Beatriz Wills, Noemí Reguart, Niki Karachaliou, Hernán Carranza, Carlos Vargas, Jorge Otero, Pilar Archila, Claudio Martín, Luis Corrales, Mauricio Cuello, Carlos Ortiz, Luis E. Pino

Integrating Models to Quantify Environment-Mediated Drug Resistance

Noemi Picco, Erik Sahai, Philip K. Maini, Alexander R.A. Anderson

Histological transformation from non‐small cell to small cell lung carcinoma after treatment with epidermal growth factor receptor‐tyrosine kinase inhibitor

Woo‐Jin Kim, Sunmin Kim, Hayoung Choi, Jinsun Chang, Hong‐Joon Shin, Cheol‐Kyu Park, In‐Jae Oh, Kyu‐Sik Kim, Young‐Chul Kim, Yoo‐Duk Choi

Clinically beneficial continued treatment with gefitinib after asymptomatic progression of lung adenocarcinoma

Hayoung Choi, Jinsun Chang, Hong‐Joon Shin, Cheol‐Kyu Park, In‐Jae Oh, Kyu‐Sik Kim, Young‐Chul Kim

The Continuation of Erlotinib Treatment in Non-Small Cell Lung Cancer Patients Whose Brain Lesion Is the Only Site of Progression: Prospective Pilot Study

Kwai Han Yoo, Seung Tae Kim, Ki Sun Jung, Ji Yun Lee, Sung Hee Lim, Min-Young Lee, Hae Soo Kim, Hee Jin Kwon, In Young Kim, Jong-Mu Sun, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn

Hanyang Medical Reviews.2015; 35(3): 180. CrossRef

Peptide Nucleic Acid Clamping Versus Direct Sequencing for the Detection of EGFR Gene Mutation in Patients with Non-small Cell Lung Cancer

Seong-Hoon Yoon, Yoo-Duk Choi, In-Jae Oh, Kyu-Sik Kim, Hayoung Choi, Jinsun Chang, Hong-Joon Shin, Cheol-Kyu Park, Young-Chul Kim

Cancer Research and Treatment.2015; 47(4): 661. CrossRef

Long Term Therapeutic Plan for Patients with Non-Small Cell Lung Cancer HarboringEGFRMutation

Tuberculosis and Respiratory Diseases.2014; 76(1): 8. CrossRef

Multiplexed immunohistochemistry, imaging, and quantitation: A review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis

Edward C. Stack, Chichung Wang, Kristin A. Roman, Clifford C. Hoyt

Comparison of pemetrexed and docetaxel as salvage chemotherapy for the treatment for nonsmall-cell lung cancer after the failure of epidermal growth factor receptor-tyrosine kinase inhibitors

Journal of International Medical Research.2014; 42(1): 191. CrossRef

Heterogeneity of epidermal growth factor receptor mutations in lung adenocarcinoma harboring anaplastic lymphoma kinase rearrangements: A case report

Post-Progression Survival in Patients with Non-Small Cell Lung Cancer with Clinically Acquired Resistance to Gefitinib

Hyojeong Kim, Tak Yun, Young Joo Lee, Ji-Youn Han, Heung Tae Kim, Geon Kook Lee

Journal of Korean Medical Science.2013; 28(11): 1595. CrossRef